Acarix AB’s Årsredovisning 2024
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2024 finns tillg&au...
Acarix AB’s Annual Report 2024
Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2024 is avail...
KALLELSE TILL ÅRSSTÄMMA I Acarix AB
Aktieägarna i Acarix AB, org.nr 559009-0667 (”Bolaget”) kallas härmed till årsstämma tisdagen den 13 m...
NOTICE OF ANNUAL GENERAL MEETING IN Acarix AB
The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the “Company”) are hereby convened to an annual general mee...
Acarix AB (publ) Publishes Year-End Report 2024 – Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts
Malmö — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial res...
Acarix AB (publ) publicerar tredje kvartalet 2024
Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat för det tredje ...
Acarix Publishes Third Quarter 2024 Report
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 202...
Acarix resolves on a directed issue to the guarantors of the warrant series 3
Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...
Acarix announces outcome of warrant exercise of series 3
Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...
Acarix informs of exercise price for the warrants of series TO 3
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...
Acarix receives additional declaration of intent and fully secures the warrants of series TO 3 through guarantee agreements
Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the Company has rec...
Acarix receives declarations of intent to exercise warrants of series TO 3
Acarix AB ("Acarix" or the "Company") has received declarations of intent to exercise Warrants of series TO 3 (the "Warrants") from a n...